课题基金 / 基金详情

Clarification of the mechanism of allergic diseases based on the analyses of the mechanism of signal transduction of interleukin-4 and-13

Clarification of the mechanism of allergic diseases based on the analyses of the mechanism of signal transduction of interleukin-4 and-13
从IL-4和IL-13信号转导机制分析阐明过敏性疾病的发病机制
批准号:
15591058
负责人:
IZUHARA Kenji
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

IZUHARA Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
虽然白介素4和白介素13参与了变态反应性疾病的发病机制,但其确切的发病机制仍不十分清楚。为了阐明这一点,我们先前通过微阵列方法在支气管上皮细胞中鉴定了IL-4或IL-13诱导的基因。我们证明了已鉴定基因中的鳞状细胞癌抗原(SCCA)1和SCCA2在哮喘患者的支气管组织和血清中的表达增强。在本研究中,我们分析了SCCA1和SCCA2的功能,虽然SCCA1和SCCA2属于丝氨酸蛋白家族,但我们发现这些分子与其他蛇类相比,对半胱氨酸蛋白酶有抑制作用。特别值得注意的是,我们发现SCCA2抑制了Der p 1的半胱氨酸蛋白酶活性,Der p 1是一种主要的粉尘变应原。这些结果表明,IL-4和IL-13通过诱导半胱氨酸蛋白酶抑制剂在防御外源性半胱氨酸蛋白酶的机制中发挥作用。此外,我们还成功地获得了一株SCCA2突变体,其对Der p1的抑制活性强于野生型SCCA2。这些结果表明,我们有可能将SCCA2本身或其类似物应用于研制一种抗粉尘过敏反应的试剂。
英文摘要
Although it is well known that interleukin(IL)-4 and IL- 13 are involved in the pathogenesis of allergic diseases, the precise mechanism of these diseases is still obscure. To clarify this point, we previously identified IL-4- or IL-13-inducible genes in bronchial epithelial cells by the microarray approach. We demonstrated that expression of the squamous cell carcinoma antigen(SCCA) 1 and SCCA2 included in the identified genes was augmented in the bronchial tissues and the serum derived from asthma patients. In this study, we analyzed the functional roles of SCCA1 and SCCA2.Although SCCA1 and SCCA2 belong to the serpin family, we found that these molecules inhibited cysteine proteases, in contrast to other serpins. Particularly, it is of note that we showed that SCCA2 inhibited the cysteine proteinase activity of Der p 1,a major mite allergen. These results indicated that IL-4 and IL-13 play a role in the defense mechanism against external cysteine proteinases by inducing cysteine proteinase inhibitors. Furthermore, we succeeded in generating a SCCA2 mutant whose inhibitory activity against Der p 1 was stronger than the wild SCCA2. These results indicated the possibility that we may apply SCCA2 itself or its analogue to development of a reagent against allergic diseases induced by mites.
期刊论文(98)
专著(0)
科研奖励(0)
会议论文
Izuhara K: "IL-4 and IL-13 : Their pathological roles in allergic diseases and their potential in developing new therapies-Update."Medical Chemistry Reviews - online. (in press).
Izuhara K:“IL-4 和 IL-13:它们在过敏性疾病中的病理作用及其开发新疗法的潜力 - 更新。”医学化学评论 - 在线。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
サイトカイン・ケモカインのすべて
关于细胞因子和趋化因子
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [Kuzuya Y, Sakata Y, Yokoi F, Izuhara K, Yasunaga S, Yokoi F, Yokoi F, Kanaji S, Tanaka G, Terada N, Tanaka G, Terada N, Izuhara K, 出原賢治]
通讯作者: 出原賢治
DOI: 10.1074/jbc.m311585200
发表时间: 2004-02-13
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Sakata, Y, Arima, K, Izuhara, K]
通讯作者: Izuhara, K
Induction and activation of the aryl hydrocarbon receptor by interleukin-4 in B cells
B 细胞中白细胞介素 4 诱导和激活芳烃受体
DOI: --
发表时间:
期刊: Inn Immunol (in press)
影响因子: --
作者: [Kuzuya Y, Sakata Y, Yokoi F, Izuhara K, Yasunaga S, Yokoi F, Yokoi F, Kanaji S, Tanaka G]
通讯作者: Tanaka G
共 49 条
    Clarification of the functional roles of matrix proteins in the pathogenesis of allergic inflammation
    • 批准号:
      23591465
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      IZUHARA Kenji
    • 依托单位:
    Functional analysis of novel effectors correlated with allergic diseases
    • 批准号:
      20591188
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      IZUHARA Kenji
    • 依托单位:
    Clarification of the underlying mechanism of allergic diseases targeting the signal pathways of the involved cytokines
    • 批准号:
      18604007
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.69万
    • 财政年份:
      2006
    • 负责人:
      IZUHARA Kenji
    • 依托单位:
    Identification of atopy genes and analyses of their functions
    海外基金